VIDMAREVE Trademark

Trademark Overview

On Tuesday, September 8, 2020, a trademark application was filed for VIDMAREVE with the United States Patent and Trademark Office. The USPTO has given the VIDMAREVE trademark a serial number of 90165962. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 11, 2024. This trademark is owned by Sanofi Pasteur Inc.. The VIDMAREVE trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for the prevention of COVID-19
vidmareve

General Information

Serial Number90165962
Word MarkVIDMAREVE
Filing DateTuesday, September 8, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements

Goods and ServicesVaccines for the prevention of COVID-19

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, October 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSanofi Pasteur Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSwiftwater, PA 18370
Party NameSanofi Pasteur Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSwiftwater, PA 18370

Trademark Events

Event DateEvent Description
Monday, March 11, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 11, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, June 30, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 29, 2023SOU EXTENSION 5 GRANTED
Wednesday, June 21, 2023SOU EXTENSION 5 FILED
Thursday, June 29, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 21, 2023SOU TEAS EXTENSION RECEIVED
Thursday, January 5, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2023SOU EXTENSION 4 GRANTED
Tuesday, January 3, 2023SOU EXTENSION 4 FILED
Tuesday, January 3, 2023SOU TEAS EXTENSION RECEIVED
Thursday, July 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 12, 2022SOU EXTENSION 3 GRANTED
Tuesday, July 12, 2022SOU EXTENSION 3 FILED
Tuesday, July 12, 2022SOU TEAS EXTENSION RECEIVED
Friday, December 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 15, 2021SOU EXTENSION 2 GRANTED
Wednesday, December 15, 2021SOU EXTENSION 2 FILED
Wednesday, December 15, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, July 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 12, 2021SOU EXTENSION 1 GRANTED
Monday, July 12, 2021SOU EXTENSION 1 FILED
Monday, July 12, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 4, 2020ASSIGNED TO EXAMINER
Wednesday, November 4, 2020PETITION TO DIRECTOR GRANTED
Sunday, November 1, 2020ASSIGNED TO PETITION STAFF
Wednesday, October 28, 2020TEAS PETITION TO DIRECTOR RECEIVED
Tuesday, October 27, 2020TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Tuesday, October 27, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, October 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 18, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, September 11, 2020NEW APPLICATION ENTERED

Related Keywords

vidmareve covid prevention vaccines